文献速递主动脉疾病

肾下腹主动脉瘤EVAR同期肾动脉支架增加30天急性肾衰竭风险

Concurrent renal artery stent during endovascular infrarenal aortic aneurysm repair confers higher risk for 30-day acute renal failure.
PubMed 文献 · J Vasc Surg · 2017-02-17

基于ACS NSQIP 2011-2014数据库6183例肾下腹主动脉瘤EVAR患者,其中281例(4.5%)同期行肾动脉血管成形与支架置入(RAAS)。

要点

  • EVAR同期RAAS与30天ARF风险升高近4倍独立相关(aOR 4.27)。
  • 既往肾病患者EVAR+RAAS后30天ARF风险升高约12倍(aOR 12.37)。
  • GFR<60、急诊状态和破裂AAA也是30天ARF的强预测因素。

核心结论

  • EVAR同期RAAS是肾下腹主动脉瘤患者术后不良肾脏结局的显著决定因素,且在校正术后ARF危险因素后仍存在。

研究设计与样本

  • 回顾性队列研究,数据来自ACS NSQIP数据库2011-2014年,共纳入6183例肾下腹主动脉瘤EVAR患者。
  • 其中281例(4.5%)同期行RAAS,与单纯EVAR组比较基线特征,并采用双变量和多变量logistic回归分析30天ARF预测因素。
  • 对既往肾病患者进行敏感性分析以评估RAAS的作用。

临床怎么用

  • 对肾下腹主动脉瘤EVAR患者,应审慎评估同期RAAS的必要性,尤其对既往肾病患者需警惕术后ARF风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Concurrent renal artery angioplasty and stenting (RAAS) during endovascular aneurysm repair (EVAR) of infrarenal abdominal aortic aneurysm (AAA) has been practiced in an attempt to maintain renal perfusion. The aim of this study was to identify the current practice of RAAS during EVAR and its effect on perioperative renal outcome. METHODS: Patients with infrarenal AAA were identified from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP, 2011-2014) database. Baseline characteristics of patients with concurrent RAAS during EVAR were compared with those of patients who underwent EVAR only. Bivariate and multivariable logistic regression analyses controlling for patients' demographics, comorbidities, and operative factors were used to evaluate the predictors of 30-day acute renal failure (ARF). Sensitivity analysis was done to evaluate the role of RAAS in patients with prior kidney disease. RESULTS: Overall, 6183 patients underwent EVAR for infrarenal AAA during the study period. Of them, 281 patients had RAAS during EVAR (4.5%). The median age of the patients was 74 years; 81.7% of the cohort was male, but a higher proportion of female patients received EVAR + RAAS compared with patients who underwent EVAR only (26.3% vs 17.9%; P < .001). There was no difference between groups in terms of comorbidities, being on dialysis, or functional status, yet the EVAR + RAAS group had a higher proportion of patients with glomerular filtration rate <60 mL/min/1.73 m2 (45.2% vs 37.2%; P = .011). RAAS was associated with significantly higher odds for development of ARF (adjusted odds ratio [aOR], 4.27; 95% confidence interval [CI], 2.06-8.84; P < .001). Other highly predictive factors of 30-day ARF were glomerular filtration rate <60 (aOR, 2.92; 95% CI, 1.47-5.78; P = .002), emergency status (aOR, 2.97; 95% CI, 1.21-7.27; P = .017), and ruptured AAA as the indication for EVAR (aOR, 4.74; 95% CI, 1.80-12.50; P = .002). Patients with prior kidney disease who had EVAR + RAAS demonstrated a 12-fold higher odds for 30-day ARF (aOR, 12.37; 95% CI, 4.66-32.89; P < .001). CONCLUSIONS: Concurrent RAAS was found to be a significant determinant of adverse renal outcomes after EVAR for infrarenal AAA. This effect was present even after controlling for patients' risk factors that might contribute to postoperative ARF.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nejim B, Arhuidese I, Rizwan M, et al. Concurrent renal artery stent during endovascular infrarenal aortic aneurysm repair confers higher risk for 30-day acute renal failure. J Vasc Surg. 2017. PMID: 28222985. doi:10.1016/j.jvs.2016.10.112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。